Trung Huynh
Stock Analyst at RBC Capital
(4.81)
# 462
Out of 4,468 analysts
297
Total ratings
76.1%
Success rate
22.9%
Average return
Main Sectors:
Stocks Rated by Trung Huynh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $60 | $58.13 | +3.22% | 20 | Jun 29, 2026 | |
| ABBV AbbVie | Maintained: Buy | $260 | $261.07 | -0.41% | 10 | Jun 22, 2026 | |
| PFE Pfizer | Upgraded: Hold | $25 | $24.32 | +2.80% | 35 | Jun 9, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,250 | $1,213.91 | +2.97% | 23 | May 21, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | n/a | $129.56 | - | 18 | May 21, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $595 → $660 | $654.27 | +0.88% | 10 | Nov 7, 2025 | |
| JSPR Jasper Therapeutics | Maintained: Buy | $29 → $25 | $0.4283 | +5,737.03% | 4 | Aug 15, 2025 | |
| INSM Insmed | Maintained: Buy | $133 → $140 | $111.60 | +25.45% | 10 | Aug 13, 2025 | |
| AMGN Amgen | Maintained: Hold | $326 → $317 | $374.15 | -15.27% | 9 | Aug 6, 2025 | |
| ALXO ALX Oncology Holdings | Maintained: Buy | $1.2 → $1 | $2.06 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $38 | $38.37 | n/a | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $7 | $3.19 | n/a | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $12 | $8.89 | n/a | 2 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.74 | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €10.00 → €13.50 | $9.02 | n/a | 9 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $175 | $263.04 | n/a | 4 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 700.00 → CHF 580.00 | $574.20 | n/a | 3 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 2,600 | $1,861.29 | n/a | 5 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 350.00 | $340.60 | n/a | 12 | Jul 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €44.00 → €40.00 | $51.35 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €14.00 → €12.00 | $11.40 | n/a | 6 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €105.00 | $170.70 | n/a | 6 | Apr 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 670.00 | $326.48 | n/a | 16 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €57.00 | $53.36 | n/a | 12 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 9,000p | $14,456.00 | n/a | 13 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $31 | $7.16 | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | 1,300p → 1,400p | $2,015.00 | n/a | 13 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €165.00 | $145.65 | n/a | 12 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €96.00 | $75.81 | n/a | 16 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 90.00 | $127.92 | n/a | 10 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €35.00 | $71.55 | n/a | 1 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $72 | $50.43 | n/a | 3 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €83.00 | $257.85 | n/a | 1 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.42 | $28.52 | n/a | 2 | Jun 25, 2020 |
Bristol-Myers Squibb Company
Jun 29, 2026
Maintained: Hold
Price Target: $60
Current: $58.13
Upside: +3.22%
AbbVie
Jun 22, 2026
Maintained: Buy
Price Target: $260
Current: $261.07
Upside: -0.41%
Pfizer
Jun 9, 2026
Upgraded: Hold
Price Target: $25
Current: $24.32
Upside: +2.80%
Eli Lilly and Company
May 21, 2026
Maintained: Buy
Price Target: $1,250
Current: $1,213.91
Upside: +2.97%
Merck & Co.
May 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $129.56
Upside: -
Regeneron Pharmaceuticals
Nov 7, 2025
Maintained: Hold
Price Target: $595 → $660
Current: $654.27
Upside: +0.88%
Jasper Therapeutics
Aug 15, 2025
Maintained: Buy
Price Target: $29 → $25
Current: $0.4283
Upside: +5,737.03%
Insmed
Aug 13, 2025
Maintained: Buy
Price Target: $133 → $140
Current: $111.60
Upside: +25.45%
Amgen
Aug 6, 2025
Maintained: Hold
Price Target: $326 → $317
Current: $374.15
Upside: -15.27%
ALX Oncology Holdings
May 21, 2025
Maintained: Buy
Price Target: $1.2 → $1
Current: $2.06
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $44 → $38
Current: $38.37
Upside: n/a
Apr 1, 2025
Maintained: Buy
Price Target: $10 → $7
Current: $3.19
Upside: n/a
Mar 29, 2025
Maintained: Buy
Price Target: $13 → $12
Current: $8.89
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $4
Current: $2.74
Upside: n/a
Aug 24, 2023
Maintained: Hold
Price Target: €10.00 → €13.50
Current: $9.02
Upside: n/a
Jul 20, 2023
Reiterated: Hold
Price Target: $170 → $175
Current: $263.04
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: CHF 700.00 → CHF 580.00
Current: $574.20
Upside: n/a
Aug 11, 2022
Maintained: Hold
Price Target: kr 2,600
Current: $1,861.29
Upside: n/a
Jul 24, 2022
Maintained: Hold
Price Target: CHF 350.00
Current: $340.60
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: €44.00 → €40.00
Current: $51.35
Upside: n/a
May 10, 2022
Maintained: Hold
Price Target: €14.00 → €12.00
Current: $11.40
Upside: n/a
Apr 13, 2022
Maintained: Hold
Price Target: €105.00
Current: $170.70
Upside: n/a
Apr 1, 2022
Maintained: Hold
Price Target: kr 670.00
Current: $326.48
Upside: n/a
Dec 13, 2021
Maintained: Hold
Price Target: €57.00
Current: $53.36
Upside: n/a
Nov 15, 2021
Maintained: Buy
Price Target: 9,000p
Current: $14,456.00
Upside: n/a
Aug 4, 2021
Maintained: Buy
Price Target: $29 → $31
Current: $7.16
Upside: n/a
Jun 22, 2021
Maintained: Sell
Price Target: 1,300p → 1,400p
Current: $2,015.00
Upside: n/a
May 13, 2021
Maintained: Buy
Price Target: €165.00
Current: $145.65
Upside: n/a
Apr 29, 2021
Maintained: Buy
Price Target: €96.00
Current: $75.81
Upside: n/a
Apr 28, 2021
Maintained: Hold
Price Target: CHF 90.00
Current: $127.92
Upside: n/a
Jan 20, 2021
Maintained: Sell
Price Target: €35.00
Current: $71.55
Upside: n/a
Oct 12, 2020
Maintained: Buy
Price Target: $55 → $72
Current: $50.43
Upside: n/a
Jul 28, 2020
Maintained: Hold
Price Target: €83.00
Current: $257.85
Upside: n/a
Jun 25, 2020
Downgraded: Hold
Price Target: $3.42
Current: $28.52
Upside: n/a